• Vt. to get $1.1 million drug settlement
    November 17,2012

    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.

    MORE IN This Just In
    AUGUSTA, Maine — The chairwoman of Maine’s Unemployment Insurance Commission has... Full Story
    BURLINGTON — The University of Vermont has received a $20 million donation — its largest... Full Story
    BROOKFIELD — A West Wardsboro resident is accused of driving drunk on Interstate 89 on Wednesday... Full Story
    More Articles
    • VIDEOS
    • PHOTOS